# A Clinical Trial to Evaluate the Safety and Efficacy of DR-2041(Synthetic Conjugated Estrogens, A) for Treatment of Vulvovaginal Atrophy

> **NCT00361569** · PHASE3 · COMPLETED · sponsor: **Duramed Research** · enrollment: 622 (actual)

## Conditions studied

- Menopause

## Interventions

- **DRUG:** DR-2041a
- **DRUG:** DR-2041b
- **OTHER:** Placebo
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT00361569
- **Lead sponsor:** Duramed Research
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-08
- **Primary completion:** 2007-09
- **Final completion:** 2007-09
- **Target enrollment:** 622 (ACTUAL)
- **Last updated:** 2015-04-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00361569

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00361569, "A Clinical Trial to Evaluate the Safety and Efficacy of DR-2041(Synthetic Conjugated Estrogens, A) for Treatment of Vulvovaginal Atrophy". Retrieved via AI Analytics 2026-08-22 from https://api.ai-analytics.org/clinical/NCT00361569. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*